Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 8.86 is 30% below its 5-year average of 12.70, near the low end of its 5-year range (7.10–39.39).
As of the fiscal period ended Tuesday, June 30, 2026. 9.20% below its 12-month average of 9.76.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 8.86.
CURRENT RATIO
8.86
CURRENT RATIO AVG TTM
9.76
CURRENT RATIO AVG 3Y
10.35
CURRENT RATIO AVG 5Y
12.70
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-9.20%
CURRENT VS 3Y AVG
-14.41%
CURRENT VS 5Y AVG
-30.20%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+135.72%
vs the sector median at left
Olema Pharmaceuticals, Inc.
Market Cap
$691.79M
Current Ratio
8.86
TTM Avg
9.76
3Y Avg
10.35
5Y Avg
12.70
Market Cap
$693.19M
Current Ratio
19.69
TTM Avg
6.38
3Y Avg
9.16
5Y Avg
11.87
Market Cap
$694.79M
Current Ratio
4.48
TTM Avg
5.45
3Y Avg
6.78
5Y Avg
8.00
Market Cap
$685.49M
Current Ratio
14.20
TTM Avg
2.62
3Y Avg
2.46
5Y Avg
2.12
Market Cap
$681.27M
Current Ratio
13.82
TTM Avg
5.67
3Y Avg
7.51
5Y Avg
7.66
Market Cap
$702.82M
Current Ratio
14.16
TTM Avg
12.98
3Y Avg
15.39
5Y Avg
17.04
Market Cap
$709.65M
Current Ratio
1.03
TTM Avg
1.26
3Y Avg
1.17
5Y Avg
1.16
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | $691.79M | 8.86 | 9.76 | 10.35 | 12.70 |
| Faeth Therapeutics, Inc. (FTH)vs › | $693.19M | 19.69 | 6.38 | 9.16 | 11.87 |
| Wave Life Sciences Ltd. (WVE)vs › | $693.61M | 9.99 | 4.68 | 3.00 | 2.74 |
| Cytek Biosciences, Inc. (CTKB)vs › | $694.79M | 4.48 | 5.45 | 6.78 | 8.00 |
| Anteris Technologies Global Corp. (AVR)vs › | $685.49M | 14.20 | 2.62 | 2.46 | 2.12 |
| Solid Biosciences Inc. (SLDB)vs › | $681.27M | 13.82 | 5.67 | 7.51 | 7.66 |
| Verastem, Inc. (VSTM)vs › | $681.02M | 2.25 | 3.08 | 3.98 | 5.01 |
| ArriVent BioPharma, Inc. (AVBP)vs › | $702.82M | 14.16 | 12.98 | 15.39 | 17.04 |
| Collegium Pharmaceutical, Inc. (COLL)vs › | $709.65M | 1.03 | 1.26 | 1.17 | 1.16 |
| MiMedx Group, Inc. (MDXG)vs › | $673.41M | 5.33 | 4.27 | 3.79 | 3.57 |
Current Ratio
8.86
Quick Ratio
8.86
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 8.86 |
| 2026-03-31 | 10.88 |
| 2025-12-31 | 9.95 |
| 2025-09-30 | 8.03 |
| 2025-06-30 | 11.09 |
| 2025-03-31 | 15.22 |
| 2024-12-31 | 10.50 |
| 2024-09-30 | 7.10 |
| 2024-06-30 | 9.13 |
| 2024-03-31 | 9.61 |
| 2023-12-31 | 12.33 |
| 2023-09-30 | 17.66 |
| 2023-06-30 | 11.56 |
| 2023-03-31 | 9.76 |
| 2022-12-31 | 12.62 |
| 2022-09-30 | 17.93 |
| 2022-06-30 | 19.75 |
| 2022-03-31 | 26.57 |
| 2021-12-31 | 32.23 |
| 2021-09-30 | 34.63 |
| 2021-06-30 | 39.39 |
| 2021-03-31 | 62.59 |
| 2020-12-31 | 74.62 |
| 2020-09-30 | 24.48 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 0.07 |
